CENTROSE, LLC

Address

918 Deming Way, STE 100
MADISON, WI, 53717-1945

Information

DUNS: 787342471
# of Employees: N/A

Ownership Information

Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N

Award Charts




Award Listing

  1. A Novel Antibody Drug Conjugate for Metastatic Renal Cancer Treatment

    Amount: $224,734.00

    Project Summary The incidence of renal cell cancer has been rising steadily and for those that have tumor recurrence after surgery, the prognosis is generally poor. In 2013 an estimated 65,150 new cas ...

    SBIRPhase I2014Department of Health and Human Services
  2. A new paradigm for antibody-directed conjugates

    Amount: $199,122.00

    DESCRIPTION (provided by applicant): Non-small cell lung cancer (NSCLC) is among the most common and lethal cancers yet, the current standard of care for advanced stage NSCLC provides only modest imp ...

    SBIRPhase I2011Department of Health and Human Services
  3. SBIR Phase I: Development of a High Throughput Glycosyl-Scanning Platform

    Amount: $150,000.00

    This Small Business Innovation Research Phase I project highlights a strategy for the development of the first integrated high throughput pipeline to synthesize and evaluate novel sugar-drug conjugate ...

    SBIRPhase I2011National Science Foundation
  4. Amphotericin B Analogs

    Amount: $277,253.00

    DESCRIPTION (provided by applicant): Current antifungal therapy is limited by the types of drugs available to treat systemic infections due to emerging and comparatively rare fungi different from the ...

    SBIRPhase I2009Department of Health and Human Services
  5. Automation of Neoglycoside Synthesis

    Amount: $198,836.00

    DESCRIPTION (provided by applicant): The process of small molecule and natural product glycorandomization developed by Thorson and coworkers has been validated as one of the first simple, efficient an ...

    SBIRPhase I2008Department of Health and Human Services
  6. STTR Phase I: Development of Bacterial Glycorandomization Hosts

    Amount: $75,000.00

    This Small Business Technology Transfer Research Phase I project develops methodology needed for the production of sugar enhanced (glycosidic) compound libraries and final therapeutic leads. Sugar att ...

    STTRPhase I2008National Science Foundation
  7. novel macrolides as anti-infective drugs

    Amount: $244,089.00

    DESCRIPTION (provided by applicant): Although it has long been known that macrolide glycosylation is absolutely essential for antibacterial activity, the megalomicins (which differ from erythromycins ...

    SBIRPhase I2007Department of Health and Human Services
  8. cardiac neoglycosides as cancer drugs

    Amount: $163,192.00

    DESCRIPTION (provided by applicant): Epidemiological evidence points to the value of cardiac glycosides like digoxin and digitoxin for treatment of breast cancer and recent reports suggest they may be ...

    SBIRPhase I2007Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government